The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activationDavid P. Kodack, Rakesh K. Jain, Angela Tam et al.|Science Translational Medicine|2017Cited by 113
Clinical responses to ERK inhibitor (GDC-0994) treatment combinations predicted using a Quantitative Systems Pharmacology model of MAPK signaling in BRAF(V600E)-mutant colorectal cancerDaniel C. Kirouac, Saroja Ramanujan, Gabriele Schaefer et al.|European Journal of Cancer|2016Cited by 2
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Teng Teng, Matthew R. Tonini et al.|Biochimica et Biophysica Acta (BBA) - Molecular Cell Research|2025Cited by 1
Abstract C048: Inducible activation of sgRNA libraries in tumor xenografts empowers large-scale in vivo target discovery screensSilvia Fenoglio, Teng Teng, James M. Tepper et al.|Molecular Cancer Therapeutics|2023Cited by 0
Tumor suppressor collateral damage screens reveal mRNA homeostasis protein HBS1L as a novel vulnerability in ch9p21 driven FOCAD deleted cancerHongxiang Zhang, Teng Teng, Matthew R. Tonini et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 0